News Releases

1 FEB 2012 [Corporate]

• Otsuka Pharmaceutical's Fukuroi Factory Receives FY2011 METI Minister Award for Factories Making an Outstanding Contribution to the Environment

18 JAN 2012 [Pharmaceuticals]

• Antipsychotic Agent ABILIFY® Receives Regulatory Approvals for Additional Indication "Improvement of Manic Symptoms Associated with Bipolar Disorder" and for New Dosage Form "ABILIFY® OD Tablets"

13 JAN 2012 [Pharmaceuticals]

• Otsuka Pharmaceutical Files New Drug Application for The Dopamine Agonist Transdermal Patch, Rotigotine Patch, in Japan

13 JAN 2012 [Pharmaceuticals]

• Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders

5 JAN 2012 [Pharmaceuticals]

• Mucosta® ophthalmic suspension UD2% releases on January 5, 2012